A
Aqua Bio Technology ASA
OSE:ABTEC
Aqua Bio Technology ASA
OSE:ABTEC
Price:
4.7005
NOK
-9.78%
Market Closed
Market Cap:
kr18.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aqua Bio Technology ASA
OSE:ABTEC
|
NO |
|
L
|
Linzhou Heavy Machinery Group Co Ltd
SZSE:002535
|
CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
CN |
|
Amex Exploration Inc
XTSX:AMX
|
CA |
|
LVMH Moet Hennessy Louis Vuitton SE
XETRA:MOH
|
FR |
|
K
|
Kyungchang Industrial
KOSDAQ:024910
|
KR |
|
Biofrontera Inc
NASDAQ:BFRI
|
US |
|
Travel + Leisure Co
NYSE:TNL
|
US |
|
Kitazawa Sangyo Co Ltd
TSE:9930
|
JP |
|
A
|
American Aires Inc
CNSX:WIFI
|
CA |
|
B
|
Bowler Metcalf Ltd
JSE:BCF
|
ZA |
|
Xebec Adsorption Inc
TSX:XBC
|
CA |
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
IN |
Balance Sheet
Balance Sheet Decomposition
Aqua Bio Technology ASA
Aqua Bio Technology ASA
Balance Sheet Decomposition is not available for
Aqua Bio Technology ASA
Aqua Bio Technology ASA
Balance Sheet
Aqua Bio Technology ASA
Aqua Bio Technology ASA
Currency: NOK
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
5
|
13
|
2
|
5
|
0
|
|
| Cash Equivalents |
5
|
13
|
2
|
5
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
3
|
3
|
20
|
15
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
6
|
8
|
24
|
6
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
6
|
22
|
13
|
49
|
38
|
|
| PP&E Net |
1
|
0
|
0
|
17
|
43
|
|
| Intangible Assets |
9
|
12
|
54
|
41
|
92
|
|
| Goodwill |
0
|
0
|
0
|
123
|
75
|
|
| Note Receivable |
0
|
0
|
0
|
7
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
123
|
75
|
|
| Total Assets |
16
N/A
|
34
+112%
|
67
+95%
|
238
+254%
|
250
+5%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
5
|
7
|
67
|
88
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
7
|
16
|
28
|
104
|
|
| Other Current Liabilities |
0
|
0
|
2
|
24
|
7
|
|
| Total Current Liabilities |
3
|
12
|
25
|
120
|
199
|
|
| Long-Term Debt |
1
|
0
|
1
|
24
|
101
|
|
| Deferred Income Tax |
0
|
0
|
2
|
7
|
18
|
|
| Other Liabilities |
3
|
4
|
38
|
1
|
13
|
|
| Total Liabilities |
8
N/A
|
16
+99%
|
65
+316%
|
152
+133%
|
331
+118%
|
|
| Equity | ||||||
| Common Stock |
46
|
52
|
52
|
119
|
272
|
|
| Retained Earnings |
38
|
33
|
50
|
69
|
401
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
36
|
48
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
19
+125%
|
2
-90%
|
86
+4 510%
|
82
N/A
|
|
| Total Liabilities & Equity |
16
N/A
|
34
+112%
|
67
+95%
|
238
+254%
|
250
+5%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
0
|
0
|
0
|
1
|
2
|
|
Switch to:
Switch to:
See Also
Discover More
